Uberti JP - Search Results

1

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Pulsipher MA, et al. Among authors: uberti jp. Biol Blood Marrow Transplant. 2019 Apr;25(4):699-711. doi: 10.1016/j.bbmt.2018.11.004. Epub 2018 Nov 10. Biol Blood Marrow Transplant. 2019. PMID: 30423480 Free PMC article.

2

Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.

Schultz KR, Ratanatharathorn V, Abella E, Eisenbrey AB, Karanes C, Lum LG, de Planque MM, Uberti JP, Ravindranath Y, Sensenbrenner LL. Schultz KR, et al. Among authors: uberti jp. Bone Marrow Transplant. 1994 Jun;13(6):817-22. Bone Marrow Transplant. 1994. PMID: 7920320

3

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.

Jacobson P, Uberti J, Davis W, Ratanatharathorn V. Jacobson P, et al. Bone Marrow Transplant. 1998 Aug;22(3):217-25. doi: 10.1038/sj.bmt.1701331. Bone Marrow Transplant. 1998. PMID: 9720734 Review.

4

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.

Ratanatharathorn V, Carson E, Reynolds C, Ayash LJ, Levine J, Yanik G, Silver SM, Ferrara JL, Uberti JP. Ratanatharathorn V, et al. Among authors: uberti jp. Ann Intern Med. 2000 Aug 15;133(4):275-9. doi: 10.7326/0003-4819-133-4-200008150-00011. Ann Intern Med. 2000. PMID: 10929168

5

Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.

Cronin S, Uberti JP, Ayash LJ, Raith C, Ratanatharathorn V. Cronin S, et al. Among authors: uberti jp. Bone Marrow Transplant. 2000 Dec;26(11):1247-9. doi: 10.1038/sj.bmt.1702694. Bone Marrow Transplant. 2000. PMID: 11149742

6

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.

Ayash LJ, Clarke M, Silver SM, Braun T, Uberti J, Ratanatharathorn V, Reynolds C, Ferrara J, Broun ER, Adams PT. Ayash LJ, et al. Bone Marrow Transplant. 2001 May;27(9):939-47. doi: 10.1038/sj.bmt.1703008. Bone Marrow Transplant. 2001. PMID: 11436104 Review.

7

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.

Reynolds C, Ratanatharathorn V, Adams P, Braun T, Silver S, Ayash L, Carson E, Eisbruch A, Dawson LA, McDonagh K, Ferrara J, Uberti J. Reynolds C, et al. Bone Marrow Transplant. 2001 Apr;27(8):801-7. doi: 10.1038/sj.bmt.1703006. Bone Marrow Transplant. 2001. PMID: 11477436 Clinical Trial.

8

Chronic graft-versus-host disease: clinical manifestation and therapy.

Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Ratanatharathorn V, et al. Among authors: uberti jp. Bone Marrow Transplant. 2001 Jul;28(2):121-9. doi: 10.1038/sj.bmt.1703111. Bone Marrow Transplant. 2001. PMID: 11509929 Review.

9

Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JL, Uberti J, Cooke KR. Yanik G, et al. Biol Blood Marrow Transplant. 2002;8(7):395-400. doi: 10.1053/bbmt.2002.v8.pm12171486. Biol Blood Marrow Transplant. 2002. PMID: 12171486

10

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V. Levine JE, et al. Among authors: uberti jp. Biol Blood Marrow Transplant. 2003 Mar;9(3):189-97. doi: 10.1053/bbmt.2003.50012. Biol Blood Marrow Transplant. 2003. PMID: 12652470 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page